Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Capricor Therapeutics (CAPR) Cash from Investing Activities (2016 - 2025)

Capricor Therapeutics has reported Cash from Investing Activities over the past 15 years, most recently at $43.1 million for Q4 2025.

  • Quarterly results put Cash from Investing Activities at $43.1 million for Q4 2025, up 134.92% from a year ago — trailing twelve months through Dec 2025 was $97.5 million (up 183.9% YoY), and the annual figure for FY2025 was $97.5 million, up 183.9%.
  • Cash from Investing Activities for Q4 2025 was $43.1 million at Capricor Therapeutics, up from $16.0 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for CAPR hit a ceiling of $43.1 million in Q4 2025 and a floor of -$123.4 million in Q4 2024.
  • Median Cash from Investing Activities over the past 5 years was -$179685.5 (2021), compared with a mean of -$2.5 million.
  • Peak annual rise in Cash from Investing Activities hit 1494.77% in 2022, while the deepest fall reached 10882.05% in 2022.
  • Capricor Therapeutics' Cash from Investing Activities stood at -$368671.0 in 2021, then surged by 1494.77% to $5.1 million in 2022, then plummeted by 214.01% to -$5.9 million in 2023, then tumbled by 2004.53% to -$123.4 million in 2024, then soared by 134.92% to $43.1 million in 2025.
  • The last three reported values for Cash from Investing Activities were $43.1 million (Q4 2025), $16.0 million (Q3 2025), and $14.5 million (Q2 2025) per Business Quant data.